English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52845814    Online Users :  653
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"shih j y"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 16-65 of 1137  (23 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-08-19T00:21:07Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial CHIUN HSU; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2022-08-12T06:28:17Z The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells Su J.-L.; Yang P.-C.; Shih J.-Y.; Yang C.-Y.; Wei L.-H.; Hsieh C.-Y.; Chou C.-H.; Jeng Y.-M.; Wang M.-Y.; KING-JEN CHANG; Hung M.-C.; Kuo M.-L.
臺大學術典藏 2022-08-12T06:28:09Z The VEGF-C/Flt-4 Axis Promotes Invasion and Metastasis of Cancer Cells (DOI:10.1016/j.ccr.2006.02.018) Su J.-L.; Yang P.-C.; Shih J.-Y.; Yang C.-Y.; Wei L.-H.; Hsieh C.-Y.; Chou C.-H.; Jeng Y.-M.; Wang M.-Y.; KING-JEN CHANG; Hung M.-C.; Kuo M.-L.
臺大學術典藏 2022-08-12T06:28:02Z The VEGF-C/Flt-4 Axis Promotes Invasion and Metastasis of Cancer Cells (DOI:10.1016/j.ccr.2006.02.018) Su J.-L.; Yang P.-C.; Shih J.-Y.; Yang C.-Y.; Wei L.-H.; Hsieh C.-Y.; Chou C.-H.; Jeng Y.-M.; Wang M.-Y.; KING-JEN CHANG; Hung M.-C.; Kuo M.-L.
臺大學術典藏 2022-08-10T02:37:42Z Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; CHIH-HSIN YANG
臺大學術典藏 2022-08-10T02:37:41Z Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; Yu C.-J.; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏 2022-08-10T02:37:40Z Real-world insights into patients with advanced NSCLC and MET alterations Bittoni M.; CHIH-HSIN YANG; Shih J.-Y.; Peled N.; Smit E.F.; Camidge D.R.; Arasada R.R.; Oksen D.; Boutmy E.; Stroh C.; Johne A.; Carbone D.P.; Paik P.K.
臺大學術典藏 2022-06-29T02:53:22Z Recurrence of pericardial effusion after different procedure modalities in patients with non-small-cell lung cancer Chang, L-K; Kuo, Y-W; SHANG-GIN WU; Chung, K-P; Shih, J-Y
臺大學術典藏 2022-06-27T07:07:54Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; CHONG-JEN YU; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:54Z Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Wu S.-G.; Gow C.-H.; CHONG-JEN YU; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:53Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; CHONG-JEN YU; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2022-06-27T07:07:53Z Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; CHONG-JEN YU; Tsai M.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:51Z Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; CHONG-JEN YU; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:07:49Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; CHONG-JEN YU; Cheng A.-L.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:47Z Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; Ho C.-C.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:45Z Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer Lee J.-H.; CHONG-JEN YU; Chen K.-Y.; Shih J.-Y.; Lin Y.-L.; Yang C.-H.
臺大學術典藏 2022-06-27T07:07:45Z Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors Chen K.-Y.; Chen J.-H.; Shih J.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:44Z Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer Wu J.-Y.; CHONG-JEN YU; Shih J.-Y.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:44Z Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors Lin C.-C.; Hsu H.-H.; Sun C.-T.; Shih J.-Y.; Lin Z.-Z.; CHONG-JEN YU; Chen G.G.; Hsin M.K.Y.; Lam K.C.; Leung L.; Yang C.-H.; Mok T.
臺大學術典藏 2022-06-27T07:07:42Z Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; CHONG-JEN YU; Chang S.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:40Z Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations Chung K.-P.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:07:39Z Epidermal growth factor receptor mutations in small cell lung cancer: A brief report Shiao T.-H.; Chang Y.-L.; CHONG-JEN YU; Chang Y.-C.; Hsu Y.-C.; Chang S.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:39Z The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma Kuo Y.-W.; Jerng J.-S.; Shih J.-Y.; Chen K.-Y.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:36Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:35Z Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer Wu J.-Y.; CHONG-JEN YU; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:35Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Wu S.-G.; Yang C.-H.; CHONG-JEN YU; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:32Z Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; CHONG-JEN YU; Shih J.-Y.
臺大學術典藏 2022-06-27T07:07:31Z Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; CHONG-JEN YU; Shih J.-Y.; Chang Y.-L.; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:31Z Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:28Z Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation Lu C.-H.; Hsiao C.-H.; Chang Y.-C.; Lee J.-M.; Shih J.-Y.; Wu L.-A.; CHONG-JEN YU; Liu H.-M.; Shih T.T.-F.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:28Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Wu S.-G.; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:27Z Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum Liao W.-Y.; Shih J.-Y.; Chang G.-C.; Cheng Y.-K.; Yang J.C.-H.; Chen Y.-M.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:07:27Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:07:26Z Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment Chung K.-P.; Huang Y.-T.; Chang Y.-L.; CHONG-JEN YU; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:54Z Elevated serum levels of mucin-associated antigen in patients with acute respiratory distress syndrome Shih J.-Y.; Yang S.-C.; CHONG-JEN YU; Wu H.-D.; Liaw Y.-S.; Wu R.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:53Z Sonographic imaging of the trachea Shih J.-Y.; Lee L.-N.; Wu H.-D.; CHONG-JEN YU; Wang H.-C.; Chang Y.-L.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:47Z Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells Shih J.-Y.; Yang S.-C.; Hong T.-M.; Yuan A.; Chen J.J.W.; CHONG-JEN YU; Chang Y.-L.; Lee Y.-C.; Peck K.; Wu C.-W.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:46Z Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure Jiang J.-R.; Shih J.-Y.; Wang H.-C.; Wu R.-M.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:41Z Digital infarcts showing microangiopathy in adult dermatomyositis suggest severe pulmonary involvement and poor prognosis [3] Tjiu J.-W.; Lin S.-J.; Wang L.-F.; Shih J.-Y.; CHONG-JEN YU; Liang C.-W.; Chu C.-Y.
臺大學術典藏 2022-06-27T07:06:41Z Sialyl Lewis antigens: Association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer CHONG-JEN YU; Shih J.-Y.; Lee Y.-C.; Shun C.-T.; Yuan A.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:37Z Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma Shih J.-Y.; Tsai M.-F.; Chang T.-H.; Chang Y.-L.; Yuan A.; CHONG-JEN YU; Lin S.-B.; Liou G.-Y.; Lee M.-L.; Chen J.J.W.; Hong T.-M.; Yang S.-C.; Su J.-L.; Lee Y.-C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:37Z Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status Su W.-P.; Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:37Z Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R Gow C.-H.; Shih J.-Y.; Chang Y.-L.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:06:35Z Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer Shih J.-Y.; Gow C.-H.; CHONG-JEN YU; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:34Z Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients Chang G.-C.; Tsai C.-M.; Chen K.-C.; CHONG-JEN YU; Shih J.-Y.; Yang T.-Y.; Lin C.-P.; Hsu J.-Y.; Chiu C.-H.; Perng R.-P.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2022-06-27T07:06:33Z Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer Yang C.-H.; Shih J.-Y.; Chen K.-C.; CHONG-JEN YU; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:29Z MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib Bean J.; Brennan C.; Shih J.-Y.; Riely G.; Viale A.; Wang L.; Chitale D.; Motoi N.; Szoke J.; Broderick S.; Balak M.; Chang W.-C.; CHONG-JEN YU; Gazdar A.; Pass H.; Rusch V.; Gerald W.; Huang S.-F.; Yang P.-C.; Miller V.; Ladanyi M.; Yang C.-H.; Pao W.
臺大學術典藏 2022-06-27T07:06:28Z Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; Chang Y.-C.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:27Z Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation Wu S.-G.; Shih J.-Y.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:25Z Cytologically proven meningeal carcinomatosis in patients with lung cancer: Clinical observation of 34 cases Chuang T.-Y.; CHONG-JEN YU; Shih J.-Y.; Yang P.-C.; Kuo S.-H.

Showing items 16-65 of 1137  (23 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page